2017 CABS BIOPACIFIC CONFERENCE

View
Event Information

Event Topic:
2017 CABS BIOPACIFIC CONFERENCE

Date/Time:
Date(s) - 06/24/17
8:30 am - 6:00 pm

Event Location:
Other, Marriott in San Mateo, 1770 South Amphlett Blvd, San Mateo, CA 94402

Speaker Information

Event Speaker:
Various

Event Speaker Title:
C Level Leaders

Event Speaker Company:
BioPacific Conference

Event Speaker Bio:

various

Event Details

Cost:
$20 Late Registration and Non-Members

Event Type
Conference

Event Details:
Theme: Leading the New Wave of Life Sciences Innovation – Technology, Policy, and Investment Trends across the Pacific Rim Our meeting will showcase: Winner of 2017 CABS K. Fong Award in Life Sciences This full-day event is expected to attract more than 500 attendees of life science professionals from the US, China and other regions Opportunities to connect with potential clients for your business Most promising areas in life sciences including cancer immunotherapy, precision medicine, and medical technology Success stories of entrepreneurs and emerging companies in US and APAC Latest biopharmaceutical development policies and regulations US-APAC cross-border investment and M&A in life sciences BioPartnering Forum to facilitate interactions including project introduction and talent recruitment between attendees and sponsors Confirmed Speakers and Panelists include: Mathai Mammen, Senior VP, Merck & Co. Atul Butte, Director, Institute for Computational Health Sciences, UCSF Thomas Hudson, VP & Head of Oncology Discovery & Early Development, AbbVie Yinxiang Wang, PhD, Co-Founder, President and CSO, Betta Pharmaceuticals Edgar Engleman, MD, Managing Partner, Vivo Capital, and Professor of Pathology and of Medicine, Stanford University Xun Xu, President, BGI Research Trevor Hawkins, Entrepreneur-in-Residence, GE Ventures Cheng Liu, CEO, Eureka Therapeutics Alexis Ji, Partner, Illumina Ventures Tarangini Deshpande, CEO, NuMedii Janet Xiao, PhD, JD, Partner, MoFo Hua Tu, PhD, CEO, Lakepharma Michael An, Founder and CEO, Curegenix Wei Zheng, Founder and CEO, Suzhou Connect Xue Tong, CEO, Kelun Botai BioPharmaceuticals John Wang, PhD, CEO, ImmuOn Therapeutics Peter Chen, CEO, mProbe Dongliang Ge, CEO, Apostle Vincent Xiang, Partner, Frontline BioVentures Li Feng, PhD, Partner, Finnegan Limin Zheng, Principal, Fish & Richardson